How Does Detox Work? The Medical Detox Process Step by Step

Medical detox works through a sequence of assessment, withdrawal-risk management, repeated reassessment and transition into continuing treatment. A patient is not simply admitted, given medication for several days and discharged when a calendar says the detox is complete. The treatment plan changes according to the substance, symptom progression, medical conditions, psychiatric status and how safely the person can function outside the withdrawal setting.

SAMHSA’s classic detox framework describes evaluation, stabilization and preparation for treatment. The current ASAM Criteria adds a broader multidimensional assessment that includes intoxication, withdrawal, addiction-medication needs, medical conditions, psychiatric conditions and the person’s recovery environment.

How Detox Works at a Glance

Step 1: Assessment and Level-of-Care Selection

The initial clinical assessment

Substance history

The detox team asks what substances are being used, how often, how much, when the last use occurred and whether use is daily, episodic or continuous. The same substance can produce very different withdrawal risk depending on duration and pattern of exposure.

Previous withdrawal

Past withdrawal is one of the most useful predictors of future concern. Previous alcohol-withdrawal seizure or delirium changes the next assessment. A history of severe benzodiazepine withdrawal also affects whether a gradual outpatient taper is appropriate or whether more intensive monitoring is needed.

Medical and psychiatric history

Heart disease, liver disease, pregnancy, seizure disorders, older age, dehydration and other medical conditions can increase risk. Suicidal thinking, psychosis, mania or severe depression can independently justify a higher level of care.

Choosing the level of care

The safest detox setting is not always inpatient. Some lower-risk alcohol withdrawal can be managed ambulatory, many opioid patients can start buprenorphine outpatient, and benzodiazepine tapers often occur over months outside a facility.

Higher-acuity care is more appropriate when withdrawal can become life-threatening, the person is medically unstable, psychiatric risk is high, several substances are involved or the home environment cannot support safe monitoring.

ASAM’s current continuum treats this as a multidimensional decision rather than a one-dimensional withdrawal score.

Step 2: Monitoring Withdrawal as It Evolves

Withdrawal is dynamic. A patient who appears stable at admission can worsen as substance levels fall. Alcohol symptoms may intensify after the person first arrives. A benzodiazepine with a long half-life can produce delayed withdrawal. Fentanyl exposure can complicate the timing of opioid symptoms.

Clinicians therefore repeat vital signs, mental-status assessment and symptom evaluation. The frequency depends on risk. Early or unstable withdrawal requires closer observation than a patient who has remained stable for an extended period.

How withdrawal scales are used

Structured tools can help standardize symptom observation. Alcohol and opioid withdrawal scales can support communication and medication decisions. Their value is consistency, not perfect prediction.

A numerical score should never override major clinical risk. A pregnant patient, someone with previous delirium, severe cardiac disease or active suicidality may need more intensive care regardless of the current score.

Step 3: Substance-Specific Treatment and Supportive Care

Alcohol withdrawal

Alcohol withdrawal treatment is designed to reduce symptoms and prevent serious complications such as seizure and delirium. Benzodiazepines are a central evidence-based medication class in clinically significant withdrawal. Nutritional treatment, including thiamine when indicated, is also important because heavy alcohol use can be associated with nutritional deficiency.

Opioid withdrawal and OUD treatment

Buprenorphine and methadone can relieve withdrawal while treating opioid use disorder. This is a crucial distinction from a comfort-medication-only detox. The medication can continue after the acute withdrawal episode rather than being stopped simply because the patient “finished detox.”

Lofexidine can reduce opioid-withdrawal symptoms but does not treat OUD in the same long-term way as buprenorphine or methadone.

Benzodiazepine dependence

The main intervention is usually a gradual individualized taper. Current ASAM-led guidance warns against abrupt discontinuation in physically dependent patients. The pace may be adjusted, paused or extended according to symptoms and risk.

Stimulants

Cocaine and methamphetamine withdrawal do not have a direct replacement medication. Treatment often centers on sleep, hydration, psychiatric safety, psychosis, depression and management of recent cardiovascular or neurologic complications.

What laboratory testing can and cannot do

Testing may include toxicology, blood counts, metabolic panels, liver-related tests, pregnancy testing, infection screening or other studies depending on the clinical picture. Laboratories are used when they help detect complications or change treatment.

A urine drug screen is not a complete detox assessment. It may miss some substances, remain positive after intoxication has ended or identify exposure without proving dependence. Clinical history and examination remain essential.

Medication reconciliation

Patients often arrive taking antidepressants, blood-pressure medication, anticonvulsants, sedatives or other prescriptions. The treatment team needs to determine what continues, what changes and what could interact with withdrawal medications.

This becomes especially important when the patient already receives buprenorphine, methadone or a benzodiazepine taper. Abruptly interrupting an appropriate treatment medication can create a new problem during the admission.

What supportive care actually does

Supportive care can include hydration, electrolyte correction, nutrition, sleep, anti-nausea treatment, treatment for diarrhea or pain, and a lower-stimulation environment. These interventions do not replace substance-specific treatment when dangerous withdrawal is present.

For example, IV fluids can help a dehydrated opioid-withdrawal patient but do not treat opioid use disorder. A sleeping medication may help insomnia but cannot replace seizure-prevention treatment in severe alcohol withdrawal.

Step 4: Reassessment, Escalation and Step-Down

How clinicians know whether detox is working

Success is not measured by a patient reporting zero discomfort. Clinicians look for stable vital signs, improvement in dangerous withdrawal features, ability to eat and drink, improved mental status, absence of escalating complications and readiness for the next level of treatment.

For opioid use disorder, successful treatment may include stabilization on buprenorphine or methadone rather than becoming completely opioid-free.

Why a patient may need a higher level

A lower-intensity plan can become unsafe if withdrawal worsens, the patient develops seizure or delirium, vomiting causes significant dehydration, psychosis becomes severe, or a medical complication emerges.

Escalation is not a failure of detox. It is the expected response to a dynamic condition when the patient’s needs exceed the original setting.

Why a patient may step down before every symptom is gone

The reverse is also true. A patient does not need to stay in an acute detox environment until sleep, anxiety and craving are completely resolved. Once intensive monitoring is no longer necessary, the patient may be better served in residential or outpatient addiction treatment where therapy and recovery work can begin in greater depth.

Step 5: Transition Into Continuing Treatment

What a warm handoff looks like

A warm handoff means the current team directly connects the patient with the next provider. It may include scheduling the appointment, sending clinical records, confirming medication continuity, arranging transportation and communicating the treatment plan.

This is stronger than simply giving the patient a list of phone numbers. The period immediately after detox can be high risk because structure disappears quickly while cravings and psychiatric symptoms may remain.

What happens if the patient leaves early

Adults can often leave voluntarily unless specific legal or medical circumstances apply. The team should explain the current risks, provide emergency instructions, address overdose prevention and make every reasonable effort to connect the person with treatment.

Leaving early can be particularly dangerous when alcohol or sedative withdrawal may still intensify or when opioid tolerance has already begun to fall.

Why polysubstance detox is different

Several withdrawal syndromes can overlap. A patient may be entering opioid withdrawal while alcohol-withdrawal seizure risk is still evolving. A stimulant crash can occur while benzodiazepine dependence creates a separate dangerous withdrawal problem.

The treatment plan prioritizes the highest-risk syndrome while managing the others at the same time.

How detox ends

Detox should end with a level-of-care transition, not simply the end of medication administration. The patient should know what medications continue, when the next appointment occurs, where they are going and what to do if symptoms return or worsen.

The most successful detox episode is one that becomes the beginning of addiction treatment rather than a repeated stand-alone cycle.

Frequently Asked Questions About How Detox Works

What happens on the first day of detox?

The team evaluates substance use, previous withdrawal, medical and psychiatric risk, current symptoms and the safest treatment setting.

Are drug tests always required?

Testing is common, but toxicology is only one part of assessment and should not replace clinical history and examination.

How often are patients checked?

Monitoring frequency depends on the substance and risk. Unstable withdrawal requires closer reassessment than a stable patient near discharge.

Does detox end when withdrawal medication stops?

No. The episode should end with a concrete transition into continuing addiction treatment.

Can the level of care change during detox?

Yes. Patients can be escalated or stepped down as withdrawal and medical or psychiatric risk changes.

Sources

• SAMHSA Evidence-Based Practices Resource Center: TIP 45, Detoxification and Substance Abuse Treatment: evaluation, stabilization and transition into continuing treatment.
• The ASAM Criteria, Fourth Edition: current person-centered addiction-treatment continuum and integration of intoxication, withdrawal and addiction-medication needs.
• ASAM Criteria: multidimensional level-of-care assessment, withdrawal risk, addiction medication needs and treatment planning.

Alcohol Withdrawal Sources

• ASAM Clinical Practice Guideline on Alcohol Withdrawal Management: ambulatory and inpatient withdrawal management, risk assessment and transition into AUD treatment.

Opioid Treatment Sources

• SAMHSA TIP 63: Medications for Opioid Use Disorder: buprenorphine, methadone and naltrexone as FDA-approved medications for OUD.
• SAMHSA: Provider Information on Treatment Options: medication treatment and overdose-prevention medications.

Benzodiazepine Sources

• Joint Clinical Practice Guideline on Benzodiazepine Tapering, 2025: gradual individualized tapering and avoidance of abrupt discontinuation in physically dependent patients.